Christian Fibiger
2009
In 2009, Christian Fibiger earned a total compensation of $2M as Chief Scientific Officer, BLS at Valeant Pharmaceuticals International, a 654% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $320,625 |
|---|---|
| Option Awards | $136,500 |
| Salary | $449,520 |
| Stock Awards | $981,500 |
| Other | $112,472 |
| Total | $2,000,617 |
Fibiger received $981.5K in stock awards, accounting for 49% of the total pay in 2009.
Fibiger also received $320.6K in non-equity incentive plan, $136.5K in option awards, $449.5K in salary and $112.5K in other compensation.
Rankings
In 2009, Christian Fibiger's compensation ranked 2,374th out of 9,885 executives tracked by ExecPay. In other words, Fibiger earned more than 76.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,374 out of 9,885 | 76th |
Division Manufacturing | 830 out of 3,690 | 78th |
Major group Chemicals And Allied Products | 161 out of 871 | 82nd |
Industry group Drugs | 95 out of 643 | 85th |
Industry Pharmaceutical Preparations | 75 out of 446 | 83rd |
Source: SEC filing on April 21, 2010.
Fibiger's colleagues
We found six more compensation records of executives who worked with Christian Fibiger at Valeant Pharmaceuticals International in 2009.
2009
William Wells
Valeant Pharmaceuticals International
Chief Executive Officer
2009
William Wells
Valeant Pharmaceuticals International
Chief Executive Officer
2009
Gilbert Godin
Valeant Pharmaceuticals International
Chief Operating Officer
2009
Gregory Gubitz
Valeant Pharmaceuticals International
General Counsel
2009
Margaret Mulligan
Valeant Pharmaceuticals International
Chief Financial Officer
2009
Mark Durham
Valeant Pharmaceuticals International